Literature DB >> 24283781

MRI in corticobasal degeneration.

M Grisoli1, V Fetoni, M Savoiardo, F Girotti, M G Bruzzone.   

Abstract

Corticobasal degeneration is a degenerative disease characterized by asymmetric brain atrophy and clinically by asymmetric onset of an akinetic-rigid syndrome with apraxia, dysarthria and dysphagia. Diagnosis must be confirmed by autopsy. We have investigated the ability of MRI to detect asymmetric atrophy to support the clinical diagnosis and permit differential diagnosis against other degenerative disorders. Ten patients with clinical suspicion of corticobasal degeneration were studied by brain MRI, and the images were reviewed with the side of greater clinical involvement unknown to the reviewer. The original reports of MR scans were also reviewed. MRI demonstrates that cortical atrophy is asymmetric and more marked in the posterior frontal and mainly in the parietal regions on the side contralateral to the clinical symptoms. Asymmetry was rarely detected on the first reading. Our review of MRI findings demonstrates that it is possible to detect asymmetrical parietal atrophy, thus supporting the clinical diagnosis of corticobasal degeneration. It is essential to be aware of the disease and alert for asymmetries in order to discern the more involved side. No abnormalities were detected in the basal ganglia. 1995 Lippincott Williams & Wilkins.

Entities:  

Year:  1995        PMID: 24283781     DOI: 10.1111/j.1468-1331.1995.tb00172.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

1.  Evaluation of cortical atrophy between progressive supranuclear palsy and corticobasal degeneration by hemispheric surface display of MR images.

Authors:  Masato Taki; Kazunari Ishii; Tetsuya Fukuda; Yoshio Kojima; Etsuro Mori
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

Review 2.  Clinical Aspects of the Differential Diagnosis of Parkinson's Disease and Parkinsonism.

Authors:  Hae-Won Shin; Sang-Wook Hong; Young Chul Youn
Journal:  J Clin Neurol       Date:  2022-05       Impact factor: 2.566

3.  Levetiracetam reduces myoclonus in corticobasal degeneration: report of two cases.

Authors:  Tibor Kovács; Marianna Farsang; Edina Vitaszil; Péter Barsi; Tamás Györke; Imre Szirmai; Anita Kamondi
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

Review 4.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.